We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock
FRTX

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

12 hedge funds and large institutions have $1.46M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

29% less funds holding

Funds holding: 17 → 12 (-5)

46% less capital invested

Capital invested by funds: $2.71M → $1.46M (-$1.25M)

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
12
Holders Change
-5
Holders Change %
-29.41%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
4
Closed
6
Calls
$179K
Puts
–
Net Calls
+$179K
Net Calls Change
-$1.17M

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$552K
2
MFG
Magnus Financial Group
New York
+$270K
3
Renaissance Technologies
Renaissance Technologies
New York
+$75.1K
4
NFG
Next Financial Group
Texas
+$2.43K

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$90K
2
BlackRock
BlackRock
New York
-$11K
3
TRCT
Tower Research Capital (TRC)
New York
-$5K
4
UBS Group
UBS Group
Switzerland
-$3K
5
Victory Capital Management
Victory Capital Management
Texas
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$664K +$552K +4,771 +94%
Renaissance Technologies
2
Renaissance Technologies
New York
$442K +$75.1K +649 +11%
MFG
3
Magnus Financial Group
New York
$158K +$270K +2,334 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$83K – – –
BlackRock
5
BlackRock
New York
$66K -$11K -95 -9%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$23K – – –
NFG
7
Next Financial Group
Texas
$10K +$2.43K +21 +16%
SPIA
8
Steward Partners Investment Advisory
New York
$3K – – –
Bank of America
9
Bank of America
North Carolina
$2K -$810 -7 -16%
Morgan Stanley
10
Morgan Stanley
New York
$2K -$463 -4 -11%
WEC
11
Winslow Evans & Crocker
Massachusetts
$2K – – –
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
– -$90K -479 Closed
TRCT
13
Tower Research Capital (TRC)
New York
– -$5K -25 Closed
UBS Group
14
UBS Group
Switzerland
– -$3K -18 Closed
PAM
15
Panagora Asset Management
Massachusetts
– -$1.97K -17 -94%
Victory Capital Management
16
Victory Capital Management
Texas
– -$2K -11 Closed
PCM
17
Princeton Capital Management
New Jersey
– -$1K -3 Closed

FRTX Hedge Fund Activity: Q4 2019 in Review

12 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q4 2019, worth a combined $1.46M — down 46% from $2.71M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of FRTX and 1 opened new positions — a net loss of 5 holders — while 4 trimmed existing stakes and 3 added.

The largest buyer was BVF Inc, adding an estimated $552K. The largest seller was Acadian Asset Management, exiting entirely with an estimated $90K sold.

  • 12 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q4 2019, down from 17 in Q3 2019.
  • Funds reported $1.46M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q4 2019, down 46% quarter-over-quarter.
  • 1 fund opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q4 2019 and 6 closed out, a net change of -5 holders.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q4 2019 was BVF Inc, an estimated $552K added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q4 2019 was Acadian Asset Management, an estimated $90K sold.

Based on aggregated 13F filings for Q4 2019.